These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 8969169)
1. The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein. Croze E; Russell-Harde D; Wagner TC; Pu H; Pfeffer LM; Perez HD J Biol Chem; 1996 Dec; 271(52):33165-8. PubMed ID: 8969169 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains. Arduini RM; Strauch KL; Runkel LA; Carlson MM; Hronowski X; Foley SF; Young CN; Cheng W; Hochman PS; Baker DP Protein Sci; 1999 Sep; 8(9):1867-77. PubMed ID: 10493588 [TBL] [Abstract][Full Text] [Related]
3. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939 [TBL] [Abstract][Full Text] [Related]
4. Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation. Russell-Harde D; Wagner TC; Perez HD; Croze E Biochem Biophys Res Commun; 1999 Feb; 255(2):539-44. PubMed ID: 10049744 [TBL] [Abstract][Full Text] [Related]
5. Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling. Nguyen VP; Saleh AZ; Arch AE; Yan H; Piazza F; Kim J; Krolewski JJ J Biol Chem; 2002 Mar; 277(12):9713-21. PubMed ID: 11786546 [TBL] [Abstract][Full Text] [Related]
6. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. Lamken P; Lata S; Gavutis M; Piehler J J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780 [TBL] [Abstract][Full Text] [Related]
7. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons. Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298 [TBL] [Abstract][Full Text] [Related]
8. Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity. Runkel L; deDios C; Karpusas M; Betzenhauser M; Muldowney C; Zafari M; Benjamin CD; Miller S; Hochman PS; Whitty A Biochemistry; 2000 Mar; 39(10):2538-51. PubMed ID: 10704203 [TBL] [Abstract][Full Text] [Related]
9. Shared receptor components but distinct complexes for alpha and beta interferons. Lewerenz M; Mogensen KE; Uzé G J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924 [TBL] [Abstract][Full Text] [Related]
10. The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action. Pfeffer LM; Basu L; Pfeffer SR; Yang CH; Murti A; Russell-Harde D; Croze E J Biol Chem; 1997 Apr; 272(17):11002-5. PubMed ID: 9110990 [TBL] [Abstract][Full Text] [Related]
11. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2. Piehler J; Schreiber G J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041 [TBL] [Abstract][Full Text] [Related]
12. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1. Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680 [TBL] [Abstract][Full Text] [Related]
13. Affinity of Stat2 for the subunits of the interferon alpha receptor. Saleh AZ; Nguyen VP; Krolewski JJ Biochemistry; 2002 Sep; 41(37):11261-8. PubMed ID: 12220192 [TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site. Roisman LC; Jaitin DA; Baker DP; Schreiber G J Mol Biol; 2005 Oct; 353(2):271-81. PubMed ID: 16171819 [TBL] [Abstract][Full Text] [Related]
15. Characterization of interferon α and β receptor IFNAR1 and IFNAR2 expression and regulation in the uterine endometrium during the estrous cycle and pregnancy in pigs. Jang H; Choi Y; Yoo I; Han J; Kim M; Ka H Theriogenology; 2017 Jan; 88():166-173. PubMed ID: 27769575 [TBL] [Abstract][Full Text] [Related]
16. Differential receptor subunit affinities of type I interferons govern differential signal activation. Jaks E; Gavutis M; Uzé G; Martal J; Piehler J J Mol Biol; 2007 Feb; 366(2):525-39. PubMed ID: 17174979 [TBL] [Abstract][Full Text] [Related]
17. The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening. Chill JH; Nivasch R; Levy R; Albeck S; Schreiber G; Anglister J Biochemistry; 2002 Mar; 41(11):3575-85. PubMed ID: 11888273 [TBL] [Abstract][Full Text] [Related]
18. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007 [TBL] [Abstract][Full Text] [Related]
19. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection. Morita K; Tanaka K; Saito S; Kitamura T; Kondo M; Sakaguchi T; Morimoto M; Sekihara H J Clin Gastroenterol; 1998 Mar; 26(2):135-40. PubMed ID: 9563926 [TBL] [Abstract][Full Text] [Related]
20. New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. Piehler J; Roisman LC; Schreiber G J Biol Chem; 2000 Dec; 275(51):40425-33. PubMed ID: 10984492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]